Newsletter Tool

Today's Rundown

Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk
UnitedHealth to acquire home health provider LHC Group in $5B deal
Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact
Pfizer, Moderna win over FDA for second round of COVID-19 boosters in older adults
Pear Therapeutics ripens after SPAC pact, predicts quintupling of revenue in 2022
ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data
Cleveland Clinic expands into Europe with opening of private London hospital near Buckingham Palace
On a roll, Sanofi raises Dupixent's peak sales target to €13B-plus
Staar Surgical scopes out FDA approval for LASIK alternative implantable lens
Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO
4 healthcare items to watch in Biden's budget proposal
LetsGetChecked expands at-home testing with bid for George Church's Veritas companies

Featured Story

Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk

By Fraiser Kansteiner

While scores of Western corporations have quit Russia in protest of its invasion of Ukraine, the pharmaceutical industry has been caught in a philanthropic juggling act: Most drugmakers have condemned the war and promised to halt new investments in Russia—but few have stopped operations altogether in the aggressor nation.

UnitedHealth to acquire home health provider LHC Group in $5B deal

By Paige Minemyer

UnitedHealth Group will acquire home healthcare provider LHC Group for $170 per share in cash, or about $5.4 billion, the healthcare giant announced Tuesday.

Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact

By Nick Paul Taylor

Sanofi has continued the breakneck pace of dealmaking activity, paying $150 million upfront to make IGM Biosciences the third partner added in a hectic month for its business development team.

Pfizer, Moderna win over FDA for second round of COVID-19 boosters in older adults

By Eric Sagonowsky

Amid the ongoing debate over the need for another round of COVID-19 boosters, the FDA has acted quickly on the matter. Pfizer and Moderna each scored FDA nods for another round of boosters in people 50 and older plus certain immunocompromised people.

Pear Therapeutics ripens after SPAC pact, predicts quintupling of revenue in 2022

By Andrea Park

In its first year-end financial report after going public via reverse merger last December, Pear Therapeutics inched past nearly all of its predictions for 2021—and planted the seeds for a much, much bigger 2022.

ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data

By Annalee Armstrong

Last week, ImmunoGen’s investors scattered on underwhelming survival data from a late-stage trial of its antibody-drug conjugate for ovarian cancer. But that was last week. This week, the company is filing an application for FDA approval based on the “positive results.”

Cleveland Clinic expands into Europe with opening of private London hospital near Buckingham Palace

By Heather Landi

Marking the latest step in its international expansion, Cleveland Clinic today opened a new, private 184-bed hospital in London across the street from the Buckingham Palace Garden.

On a roll, Sanofi raises Dupixent's peak sales target to €13B-plus

By Eric Sagonowsky

Over the years, as Sanofi and Regeneron's Dupixent racked up new indications and approached the French pharma giant's 10 billion euro peak sales goal, analysts had started to wonder whether the drug might end up overshooting the target. With Dupixent now well on the way, Sanofi is raising its peak sales ambitions on the star drug to more than 13 billion euros.

PM Tracker

Featured Story

Merck, Roche and J&J among pharma players weighing Russian operations amid humanitarian tightrope walk

Top Stories

UnitedHealth to acquire home health provider LHC Group in $5B deal

Sanofi pulls IGM into dealmaking whirlwind, paying $150M upfront to form 6-target R&D pact

Pfizer, Moderna win over FDA for second round of COVID-19 boosters in older adults

Pear Therapeutics ripens after SPAC pact, predicts quintupling of revenue in 2022

ImmunoGen files ovarian cancer ADC with FDA, a week after scaring investors with iffy survival data

Cleveland Clinic expands into Europe with opening of private London hospital near Buckingham Palace

On a roll, Sanofi raises Dupixent's peak sales target to €13B-plus

Staar Surgical scopes out FDA approval for LASIK alternative implantable lens

Karyopharm hoping for some Keytruda stardust as former Merck & Co. exec joins as CMO

4 healthcare items to watch in Biden's budget proposal

LetsGetChecked expands at-home testing with bid for George Church's Veritas companies